With me today are Robert Ford, Chairman and Chief Executive Officer, and Philip Boudreau, Executive Vice President, Finance ...

Abbott Laboratories (NYSE:ABT) detailed fourth-quarter 2025 results and outlined its 2026 outlook on its earnings conference call, emphasizing continued momentum in medical devices, a transition plan ...